Drawing for VIGIFLU

USPTO serial 79022924

VIGIFLU

Reviewed by CopyMark Law Group

Reg. 3298218Status 404
Filing date
Status date
Registration date
Sep 25, 2007
Examiner
SAPP, HEATHER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIGIFLU?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Midge M. Hyman

MIDGE M. HYMAN COWAN, LIEBOWITZ & LATMAN, P.C.1133 AVENUE OF THE AMERICASNEW YORK, NY 10036-6799UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of influenza; veterinary preparations for the treatment of influenza; sanitary preparations for medical purposes; chemical preparations for medical use; vaccines; disinfectants, namely, disinfectants for medical use; antiseptic preparations; anti-bacterial preparations for the treatment of influenzaSECTION 71 - CANCELLED
041Educational services, namely arranging and conducting conferences, conventions, committees, colloquiums, and workshops in the pharmaceutical and medical fields; training services in the pharmaceutical and medical fields; publishing of magazines, books, handbooks, databases, and reports in the pharmaceutical and medical fieldsSECTION 71 - CANCELLED
042Medical and scientific research services, namely, clinical research and biological research in the field of pharmaceuticalsSECTION 71 - CANCELLED
044Medical services, namely, administering medicines and vaccines; providing medical assistance and consultancy services in the field of pharmacy and healthSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 2, 2016DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Oct 2, 2016DETHDEATH OF INTERNATIONAL REGISTRATION
Jun 26, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB
Jun 5, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 5, 2015INPCINVALIDATION PROCESSED
Jan 2, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 2, 2014C71TCANCELLED SECTION 71
Jul 21, 2012ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 10, 2011ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 26, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB
Jan 10, 2008FIMPFINAL DISPOSITION PROCESSED
Dec 26, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 25, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 10, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 20, 2007NPUBNOTICE OF PUBLICATION
Apr 30, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 30, 2007CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 30, 2007ALIEASSIGNED TO LIE
Mar 30, 2007MAILPAPER RECEIVED
Mar 27, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2007CNEAEXAMINERS AMENDMENT MAILED
Mar 22, 2007XAECEXAMINER'S AMENDMENT ENTERED
Mar 22, 2007CNEAEXAMINERS AMENDMENT -WRITTEN
Mar 21, 2007CRMLCORRESPONDENCE MAILED
Mar 20, 2007XAECEXAMINER'S AMENDMENT ENTERED
Mar 20, 2007CNEAEXAMINERS AMENDMENT -WRITTEN
Mar 20, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 20, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 20, 2006RFNTREFUSAL PROCESSED BY IB
Sep 28, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 28, 2006RFRRREFUSAL PROCESSED BY MPU
Sep 28, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 27, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2006RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Sep 26, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 25, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2006RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Aug 24, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 23, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2006DOCKASSIGNED TO EXAMINER
May 26, 2006NWAPNEW APPLICATION ENTERED
May 25, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance